Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(8 sites)
United States
Angeles Clinic and Research Center, Los Angeles, California University of Florida Health, Gainesville, Florida Henry Ford Health Center, Detroit, Michigan Fox Chase Cancer Center, Philadelphia, Pennsylvania MD Anderson Cancer Center, Houston, Texas Japan
National Cancer Center Hospital East, Kashiwa, Chiba The University of Osaka Hospital, Suita, Osaka National Cancer Center Hospital, Chuo Ku, Tokyo